ROS Fusion Tyrosine Kinase Activates a SH2 Domain–Containing Phosphatase-2/Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Signaling Axis to Form Glioblastoma in Mice
Al Charest(Beth Israel Deaconess Medical Center), David E. Housman(Center for Cancer Research)
Cited by 166
Related Papers
Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression
|Nature Immunology|2022|290
A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine
|Nature Communications|2018|51
Pleiotropic tumor suppressive functions of PTEN missense mutations during gliomagenesis
|iScience|2024|4
Heterogeneity of Extracellular Vesicles and Non‐Vesicular Nanoparticles in Glioblastoma
|Journal of Extracellular Vesicles|2025|3